GSK goes hostile with $2.6 billion Human Genome offer – Reuters

Buying Human Genome would give GSK full rights to these partnered drugs, underscoring the appetite among big drugmakers for biotech products to refill their medicine chests. Human Genome’s board spurned the approach from Britain’s biggest …